Lingtai Biotechnology Funding: $39M Raised, Series A (2024)
Lingtai Biotechnology is based in Shanghai, China. It has raised $39M in total funding. Latest round: Series A.
Lingtai Biotechnology funding overview
Lingtai Biotechnology is based in Shanghai, China. Lingtai Biotechnology has raised $39M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2024. The round record for Lingtai Biotechnology runs through 2024; nothing later has been disclosed. Investors on record include Beijing Lapam Venture Capital, Tianrui Fengnian, Zhangjiang Hi-Tech. 3 distinct backers are named across the disclosed rounds.
Frequently asked about Lingtai Biotechnology funding
How much has Lingtai Biotechnology raised?
Lingtai Biotechnology has raised $39M in total disclosed funding across the rounds on record.
Who has invested in Lingtai Biotechnology?
Beijing Lapam Venture Capital, Tianrui Fengnian, Zhangjiang Hi-Tech are named among the investors backing Lingtai Biotechnology.
What was the latest Lingtai Biotechnology funding round?
The most recent disclosed round is a Series A, announced in January 2024.
Where is Lingtai Biotechnology based?
Lingtai Biotechnology is based in Shanghai, China.
When did Lingtai Biotechnology last raise?
The last disclosed Lingtai Biotechnology round closed in January 2024 at Series A.
Lingtai Biotechnology totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Shanghai below to benchmark round size and investor mix.
